Document is current

Any future updates will be listed below

Neu aufgetretene Nagelpsoriasis nach Therapie mit Pembrolizumab und Durvalumab

Crossref DOI link: https://doi.org/10.1007/s00105-025-05496-y

Published Online: 2025-04-01

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark